Aptevo Therapeutics Announces 1-for-20 Reverse Stock Split as part of Nasdaq Compliance Plan

May 22, 2025 8:05 AM

Aptevo Therapeutics Inc. (NASDAQ:APVO) ("Aptevo" or the "Company"), today announced that it will conduct a reverse stock split of its outstanding shares of common stock, par value $0.001 per share ("Common Stock"), at a ratio of 1-for-20 (the "Reverse Stock Split"). The Reverse Stock Split is expected to become effective on May 23, 2025, at 5:01 p.m. Eastern Time (the "Effective Time"), with shares expected to begin trading on the Nasdaq Capital...

Read more

Ainos Showcases Breakthrough AI Nose Technology at COMPUTEX 2025 with Japan's Robotics Partner

May 22, 2025 8:00 AM

Ainos, Inc. (NASDAQ:AIMD)(Nasdaq:AIMDW) ("Ainos"), a pioneer in AI-driven scent digitization, announced the official debut of its proprietary AI Nose platform at COMPUTEX 2025, alongside ugo, Inc, Japan's top service robotics company. This milestone marks the first public demonstration of real-time robotic olfaction-a new sensory category poised to transform smart robotics, environmental AI, and safety infrastructure. This year's COMPUTEX...

Read more

Modular Medical to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025

May 22, 2025 8:00 AM

Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly and affordable design, today announced it will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2025 Investor Conference, taking place virtually, on...

Read more

The New Rational FDA COVID Vaccine Policy is Long Overdue, Says NanoViricides' Dr. Diwan

May 22, 2025 6:30 AM

Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the "Company"), comments on the new COVID Vaccine policy adopted by the US FDA.The new FDA COVID Vaccine Booster Shots policy [1] is based on the findings that the groups that benefit from repeat of vaccination (i.e. booster shots) are the groups that are likely to be at risk of severe COVID disease from the virus. These groups include all adults over 65 years of age, and...

Read more

Genflow Biosciences PLC Announces AGM Notice

May 22, 2025 6:20 AM

Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company") an emerging leader in the field of longevity research, focused on developing therapeutic solutions for the prevention of age-related diseases is pleased to announce that it will hold its Annual General Meeting ("AGM") at 9am on Thursday 12 June 2025 at One Heddon Street, London, W1B 4BD.The Notice of the AGM ("Notice") and 2025 Form of Proxy will shortly be available on...

Read more

Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

May 22, 2025 6:00 AM

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Jacob Liawatidewi, EVP of Corporate Administration, will be participating in an Analyst-Moderated fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 5th, 2025, at 2:00 pm ET. For access, visit Amphastar's Pharmaceuticals website at http://ir.amphastar.com. This webcast will be available for 30 days following the presentation.About...

Read more

AGFA HealthCare North America Reports Strong Q1 2025 Momentum With Major Enterprise Imaging Expansion and Strategic Customer Wins

May 22, 2025 6:00 AM

In the North America region, AGFA HealthCare is pleased to report a strong start to 2025, marked by significant advancements in customer partnerships, Enterprise Imaging solution expansions - on-premises and in the cloud - and continued growth in market reach during the first quarter.Quarter 1 HighlightsAGFA HealthCare's Enterprise Imaging (EI) Platform and EI Cloud continued to prove their value across the healthcare continuum, with customers...

Read more

Relief Therapeutics Receives FDA Rare Pediatric Disease Designation for RLF-TD011

May 22, 2025 1:20 AM

RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY ) (Relief or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease (RPD) designation to RLF-TD011 for the treatment of epidermolysis bullosa (EB), a rare genetic skin disorder characterized by...

Read more

Medicure Reports Financial Results for Quarter Ended March 31, 2025 and Annual General Meeting Director Election Results

May 21, 2025 5:00 PM

Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC Pink:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today reported its results from operations for the quarter ended March 31, 2025.The Company is also pleased to announce the voting results for the election of directors at its annual meeting of shareholders held...

Read more

Epica International, Inc. Announces Strategic Service Partnership With Catalyst MedTech

May 21, 2025 3:30 PM

Epica International, a global innovator in veterinary and human diagnostic imaging systems, today announced a new strategic partnership with Catalyst MedTech, a nationally recognized leader in medical imaging service and support. The partnership strengthens Epica's commitment to delivering fast, responsive, and expert service to its growing base of U.S. customers.Catalyst MedTech brings decades of experience in the diagnostic imaging field and a...

Read more

New NCQA Limited-Series Podcast Focuses on Accelerating Quality Improvement

May 21, 2025 1:00 PM

The National Committee for Quality Assurance (NCQA) today announced the launch of "Quality Talks With Peggy O'Kane," a limited-series podcast hosted by the organization's president and founder. The podcast features conversations with leaders across the health care industry, and covers quality, avenues to progress and barriers to improvement. Each episode explores how technology, primary care revitalization and systematic strategies can drive...

Read more

MD Clarity Unveils Major Expansion of Its Denial Management Module to Optimize the Revenue of Provider Organizations

May 21, 2025 1:00 PM

MD Clarity, a leading provider of revenue optimization software, today announced the launch of a major expansion of its denial management module. This offering empowers healthcare providers to identify, appeal, and analyze denials, facilitating optimal reimbursement.The preponderance of denials leads to both significant lost revenue and a meaningful workload burden for providers. MD Clarity's denial management module addresses these challenges...

Read more

CORRECTING and REPLACING: Tribun Health Achieves FDA Clearance for CaloPix Digital Pathology Platform With Dual Scanner Compatibility

May 21, 2025 10:30 AM

Tribun Health, a leader in digital pathology, proudly announces that its flagship web-based image management system, CaloPix®, has received FDA 510(k) clearance for use with two leading whole slide imaging scanners: the Hamamatsu NanoZoomer S360MD and the Leica Aperio GT450 DX. This double clearance is representing a major step forward for the U.S. adoption of vendor-agnostic, enterprise-grade solutions.This clearance builds on CaloPix's strong...

Read more

Dr. Todd H. Lanman and Dr. Jared Ament Perform First-Ever Combined Implantation of MOTUS Device and TOPS(TM) System at Adjacent Lumbar Levels

May 21, 2025 10:00 AM

In a groundbreaking advancement for motion-preserving spine surgery, renowned spinal neurosurgeon Dr. Todd H. Lanman and his colleague Dr. Jared Ament have successfully completed the first known case of combined implantation of the MOTUS total joint replacement device (developed by 3Spine, Inc.) at L5-S1 and the TOPS™ System at L4-5. The procedure was performed in Beverly Hills on a young man suffering from severe facet disease.This historic...

Read more

Protagenic Therapeutics Receives $3.1 Million from Recent Warrant Activity

May 21, 2025 9:15 AM

Protagenic Therapeutics, Inc. (Nasdaq:PTIX) (the "Company") announced today that warrant exchanges and exercises over the last four trading days have generated $3.1 million in cash. The proceeds will fund working-capital needs and advance the Company's peptide-based drug candidates for stress-related and central-nervous-system disorders. This financing comes as Protagenic executes on its previously announced business combination with Phytanix...

Read more

Telomir Pharmaceuticals Secures $3 Million at a Premium in Straight Equity Sale Involving No Warrants to Advance Rare Disease IND

May 21, 2025 9:00 AM

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), an emerging leader in age-reversal science, today announced it has secured $3 million in equity financing, through a direct investment by The Bayshore Trust, the Company's largest shareholder.The transaction involved the purchase of 1 million restricted shares of the Company's common stock at $3.00 per share, representing an 18% premium to Telomir's closing share price of...

Read more

Spinal Rehab & Sports Medicine Celebrates Two-Year Milestone of Dr. Josh Meyer, D.C. - Extending a Legacy of Excellence in Austin, TX

May 21, 2025 8:00 AM

Spinal Rehab & Sports Medicine, a cornerstone of sports injury recovery and performance care in Austin for over 25 years, proudly celebrates the two-year anniversary of Dr. Josh Meyer, D.C.-marking a generational milestone in the clinic's continued commitment to clinical excellence and patient-centered care. The son of founder Dr. Bob Meyer, D.C., Dr. Josh's addition to the team represents more than just expanded services; it signals the future...

Read more

Jaguar Health Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

May 21, 2025 8:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or "the Company"), today announced that it has entered into definitive agreements for the purchase and sale of 246,306 shares of common stock at a purchase price of $6.09 per share in a registered direct offering priced at-the-market under Nasdaq rules. In a concurrent private placement, the Company agreed to issue to investors unregistered warrants to purchase up to 492,612 shares of common stock at...

Read more

Interactive Strength Inc. (Nasdaq:TRNR) Updates FAQ's In Response To Additional Shareholder Questions

May 21, 2025 8:00 AM

Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the CLMBR and FORME brands and pending acquirer of Sportstech and Wattbike, today announced that it has updated its investor FAQ's on its investor website in response to shareholder questions around its AGM date and other corporate actions.For more commentary, information and details on the rationale for and structure of the...

Read more

Protagonist Therapeutics to Participate in the Jefferies Global Healthcare Conference 2025

May 21, 2025 7:05 AM

Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will present a company overview at the Jefferies Global Healthcare Conference taking place June 3-5, 2025, in New York, NY. The Company will also participate in one-on-one meetings.Jefferies Global Healthcare Conference - June 3-5, 2025Format: Company PresentationDay/Time: Wednesday, June 4 at 1:25...

Read more